ciba RJ, Keyes DG , Beyer JE. et aL Results of a two - year chr 〔 } nic toxicity and oncogenicity study of 2. 3. 7. 8 -tetrachlorodibenz〔} ・ p ・ dioxin in rats . Toxicot App [ Pharmacol l978; 46: 279 -303. 34)Della PG , Dragani TA , Sozzi G , Careinogenic effects 〔 } f infantile and iongterrn 2β. 7, 8 -tetrach] orodibenzo -P -dioxin treatment in the mouse . Tumori l987 : 73: 99 -107, 35) United Sta正es National Toxicology Program. Bioassay of a Mixture of l. 2 , 3. 6, 7, 8 -Hexachlorodibenzopdioxin and 1, 2. 3. 7. &9 ・ Hexachlorodibenzop . dioxi 囗 〔 CAS No .57653 -85 -7and CAS No . 19408 -74 -3}for Possible Carcinogenicity ( Gavage Study} 〔 Tech . Rep , Series No . 198; DHHS Publication No . { NIH )80 -1754 ) , Bcthesda , MD , Natiena ] Cancer Institute , 1980a. 36 ) Un { ted States Nat[ onal Toxicotogy Program 、 Bioassay of a Mixture 〔 } f 1. 2、 3, 6, 7, 8 -Hexachlorodibenzo . pdioxin and L2. 3, 78 , 9 -Hexachlorodibenzopdioxin( 〔 〕 AS No . 57653 -85 -7and CAS No .19408 -74 -3)
No takes yet. Share an insight, caveat, or question.
許容濃度等に関する委員会 日本産業衛生学会 (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: